Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-24-000589
Filing Date
2024-04-09
Accepted
2024-04-09 16:12:07
Documents
74
Period of Report
2024-02-29

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q lxrp_10q.htm   iXBRL 10-Q 942834
2 EXECUTIVE EMPLOYMENT AGREEMENT lxrp_ex105.htm EX-10.5 139664
3 AMENDED AND RESTATED INTELLECTUAL PROPERTY LICENSE AGREEMENT lxrp_ex106.htm EX-10.6 204021
4 CERTIFICATION lxrp_ex311.htm EX-31.1 12056
5 CERTIFICATION lxrp_ex312.htm EX-31.2 9497
6 CERTIFICATION lxrp_ex321.htm EX-32.1 4206
7 CERTIFICATION lxrp_ex322.htm EX-32.2 4339
13 lxrp_ex106img5.jpg GRAPHIC 3920
14 lxrp_10qimg19.jpg GRAPHIC 1582
15 lxrp_ex106img6.jpg GRAPHIC 3960
  Complete submission text file 0001640334-24-000589.txt   5234442

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20240229.xsd EX-101.SCH 47126
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20240229_lab.xml EX-101.LAB 275509
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20240229_cal.xml EX-101.CAL 45777
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20240229_pre.xml EX-101.PRE 233526
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20240229_def.xml EX-101.DEF 114995
78 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_10q_htm.xml XML 792024
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-39874 | Film No.: 24832855
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)